Fudan University: Phase 3 study in Locally Advanced Colon Cancer, pMMR (480 participants)
Fudan University: Phase 3 study in Locally Advanced Colon Cancer, pMMR (480 participants). Its enrollment of 480 is above the median of 80 (89th percentile). Dated 19 days ago, it is in the active follow-up window. Score 55/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 480 · 89th percentile of 8,879 ClinicalTrialStartPulse records · 6.0x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Fudan University |
| Sponsor type | Academic and hospital |
| Study | Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS |
| NCT ID | NCT07877597 |
| Phase | Phase 3 |
| Status | not yet recruiting |
| Conditions | Locally Advanced Colon Cancer; pMMR |
| Intervention types | radiation, drug |
| Target enrollment | 480 |
| Site countries | China |
| Posted | 2026-10-16 |
| Planned start | 2026-10-15 |
| Event | Newly registered study |
| Event date | 2026-10-16 |
| enrollment percentile | 89th of 8,879 (median 80, 6.0x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Fudan University
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Fudan University + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-16
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Fudan University and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Fudan University's enrollment: 89th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Score
- Phase 3: multi-site, larger budget.
- 480 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for Fudan University?
Fudan University registered a Phase 3 study (NCT07877597) in Locally Advanced Colon Cancer targeting 480 participants, posted 2026-10-16.
How does Fudan University compare to other ClinicalTrialStartPulse records?
Its enrollment of 480 sits in the upper half (89th percentile) of 8,879 records; the median is 80. It is 19 days old, still within a typical 45-day follow-up window.
Fudan University vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Fudan University | NONUS | 480 | 89th | 2026-10-16 |
| Janssen Research & Development, LLC | US | 539 | 90th | 2026-11-03 |
| Genmab | US | 600 | 91st | 2026-11-03 |
| GlaxoSmithKline | NONUS | 610 | 91st | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 3 ClinicalTrialStartPulse: Outside the US only
How to monitor Fudan University and peer phase 3 records
Get new ClinicalTrialStartPulse records like Fudan University by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.